154 related articles for article (PubMed ID: 16117431)
1. [Use of lozartan in patients with chronic cor pulmonale].
Butorov IV; Butorov SI
Klin Med (Mosk); 2005; 83(7):65-9. PubMed ID: 16117431
[TBL] [Abstract][Full Text] [Related]
2. [Blockers of angiotensin receptors: a novel approach to the treatment of secondary pulmonary hypertension].
Butorov IV; Verbitskiĭ ON; Butorov SI
Ter Arkh; 2004; 76(6):84-7. PubMed ID: 15332584
[TBL] [Abstract][Full Text] [Related]
3. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
[TBL] [Abstract][Full Text] [Related]
4. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
[TBL] [Abstract][Full Text] [Related]
5. [Use of the ACE inhibitor perindopril in patients with chronic obstructive lung diseases, complicated by cor pulmonale].
Vutorov IV; Butorov SI; Maksimov VV; Kureker' SI
Klin Med (Mosk); 2005; 83(9):49-53. PubMed ID: 16279041
[TBL] [Abstract][Full Text] [Related]
6. [State of vasoregulative function of vascular endothelium and cardiohemodynamics in patients with chronic obstructive diseases of the lung (CODL) treated with losartan].
Rodionova VV; Lysenko AO; Ruchko VI; Lysenko OA
Lik Sprava; 2007; (5-6):111-7. PubMed ID: 18416173
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
8. [Efficiency of ramipril treatment in patients with chronic obstructive bronchitis complicated by chronic cor pulmonale].
Butorov IV; Vatulin VN; Bodrug NI; Fuduleĭ RF; Matkovskiĭ SK; Butorova VG
Probl Tuberk; 1999; (6):42-4. PubMed ID: 10715959
[TBL] [Abstract][Full Text] [Related]
9. [A new approach to treating secondary pulmonary hypertension].
Butorov IV; Verbitskiĭ ON; Butorov SI
Probl Tuberk Bolezn Legk; 2005; (9):33-6; discussion 36. PubMed ID: 16279515
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of losartan treatment of right ventricular cardiac insufficiency in patients with chronic obstructive bronchitis].
Butorov IV; Verbitskiĭ ON; Butorov SI; Paraska VI
Klin Med (Mosk); 2003; 81(7):48-51. PubMed ID: 12934312
[TBL] [Abstract][Full Text] [Related]
11. [Indications for the use of molsidomine in patients with chronic cor pulmonale].
Gavrisiuk VK; Iachnik AI; Diachenko AP; Krasnostup NA; Morskaia ND
Klin Med (Mosk); 1988 Jun; 66(6):56-9. PubMed ID: 3184805
[No Abstract] [Full Text] [Related]
12. [Clinical observation of fominoben hydrochloride on its blood gas value influence in the patient with chronic bronchitis, emphysema and cor pulmonale (author's transl)].
Pang ZH
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Mar; 4(3):153-4. PubMed ID: 6459222
[No Abstract] [Full Text] [Related]
13. [Nifangin in the combined treatment of chronic cor pulmonale].
Butorov IV; Matkovskiĭ SK; Butorova VG
Vrach Delo; 1990 Nov; (11):24-7. PubMed ID: 2098975
[TBL] [Abstract][Full Text] [Related]
14. [Current problems in the diagnosis, prevention and treatment of chronic cor pulmonale].
Sil'vestrov VP; Surovov IuA; Semin SN
Ter Arkh; 1985; 57(11):104-9. PubMed ID: 3936208
[TBL] [Abstract][Full Text] [Related]
15. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
Krupicka J; Ceypová K; Kristenová P; Hauser T
Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
[TBL] [Abstract][Full Text] [Related]
16. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
Abe M; Okada K; Matsumoto K
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy.
Wagatsuma Y; Naritaka Y; Shimakawa T; Kanako H; Keiichiro I; Shunichi S; Konno S; Katsube T; Ogawa K
Hepatogastroenterology; 2006; 53(68):171-4. PubMed ID: 16608017
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of blood rheological disorders and their role in the progression of chronic obstructive bronchitis].
Danilov IP; Makarevich AE
Ter Arkh; 1985; 57(3):19-22. PubMed ID: 4002159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
